{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P18848",
      "entity_text" : "ATF4",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:Q9NSA1",
      "entity_text" : "FGF21",
      "features" : [ {
        "modification_type" : "unknown",
        "feature_type" : "modification"
      } ],
      "entity_type" : "gene_or_gene_product"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Furthermore, the decrease of key proteins associated with the PERK-eIF2alpha-ATF4-CHOP signaling pathway, including p-PERK, p-eIF2alpha, ATF4 and CHOP mediated by FGF21 overexpression were reversed following treatment with FGFR1 and ERK1/2 inhibitors (XREF_FIG).",
  "reading_complete" : "2020-08-03T17:19:44Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T17:18:22Z",
  "trigger" : "mediated",
  "evidence" : [ "ATF4 and CHOP mediated by FGF21" ],
  "pmc_id" : "5627875",
  "score" : 0
}